What is Medifast Inc Quarterly Revenue?

Medifast Inc Quarterly Revenue Medifast Inc Dec-2024 Quarterly Revenue is $119 Million which is growth of -37.7% YoY.

What is Medifast Inc Quarterly Net Profit?

Medifast Inc Quarterly Net Profit Medifast Inc Dec-2024 Quarterly Net Profit is $1 Million which is growth of -86.7% YoY.

What is Medifast Inc Annual Revenue?

Medifast Inc Annual Revenue Medifast Inc Dec-2024 Annual Revenue is $602 Million which is growth of -43.8% YoY.

What is Medifast Inc Annual Net Profit?

Medifast Inc Annual Net Profit Medifast Inc Dec-2024 Annual Net Profit is $2 Million which is growth of -97.9% YoY.

What is Medifast Inc Total Shareholders Fund?

Medifast Inc Total Shareholders Fund Medifast Inc Dec-2024 Total Shareholders Fund is $210 Million which is growth of 4.3% YoY.

What is Medifast Inc Total Assets?

Medifast Inc Total Assets Medifast Inc Dec-2024 Total Assets is $284 Million which is growth of -8.3% YoY.

What is Medifast Inc Book Value Per Share?

Medifast Inc Book Value Per Share Medifast Inc Book Value Per Share is $19 which is growth of 8.4% YoY.

What is Medifast Inc ROE?

Medifast Inc ROE Medifast Inc ROE is 1% which is growth of 54.8% YoY.

What is Medifast Inc Cash From Operating Activity?

Medifast Inc Cash From Operating Activity Medifast Inc Dec-2024 Cash From Operating Activity is $24 Million which is growth of -83.4% YoY.

What is Medifast Inc Net Cash Flow?

Medifast Inc Net Cash Flow Medifast Inc Dec-2024 Net Cash Flow is $-4 Million which is growth of -152.2% YoY.

What is Medifast Inc Annual Revenue?

Medifast Inc Annual Revenue fell 43.8%, in the last year to $602.46 M. Its sector's average revenue growth for the last fiscal year was 8.12%.

What is Medifast Inc Annual Net Profit?

Medifast Inc Annual Net Profit fell 97.9% in the last year to $2.09 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

What is Medifast Inc Price to Earning Ratio?

Medifast Inc Price to Earning Ratio is 62.32, higher than its sector PE ratio of 22.77.

What is Medifast Inc Stock Price?

Medifast Inc Stock Price fell 63.26% and underperformed its sector by 67.44% in the past year.

What is Medifast Inc Quarterly Revenue?

Medifast Inc Quarterly Revenue fell 37.7% YoY to $119 M. Its sector's average revenue growth YoY for the quarter was 9.6%.

What is Medifast Inc Quarterly Net profit?

Medifast Inc Quarterly Net profit fell 86.73% YoY to $0.8 M. Its sector's average net profit growth YoY for the quarter was 36.99%.

What is Medifast Inc Debt to Equity Ratio?

Medifast Inc Debt to Equity Ratio of 0.08 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Medifast Inc Return on Equity(ROE)?

Medifast Inc Return on Equity(ROE) for the last financial year was 1.02%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Medifast Inc Mutual Fund Holding?

Medifast Inc Mutual Fund Holding decreased by 1.1% in the last quarter to 43.51.

What is Medifast Inc Promoter Share Holding?

Medifast Inc Promoter Share Holding increased by 1.25% in the most recent quarter to 3.63%.

What is Medifast Inc Institutional Holding?

Medifast Inc Institutional Holding increased by 0.03% in the last quarter to 79.64.

How is the Medifast Inc today?

The Medifast Inc today is trading in the down by -1.89% at 11.92.

How has Medifast Inc performed historically?

The Medifast Inc is currently trading down -1.89% on an intraday basis in the past week the index fell -6.22%. The index has been down -23.20% in the past quarter and fell -63.26% in the past year. You can view this in the overview section.

Medifast Inc XNYS: MED

Medifast Inc Live Share Price Today, Share Analysis and Chart

Name: Medifast Inc: Is Infosys Ltd. worth buying?
Item: Medifast Inc
Rating: 1.95459725
Author: Trendlyne DVM scores

Falling Comet

Download real time

11.92 -0.23 (-1.89%)

New 52W Low in past week

133.4K XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Medifast Inc is on 29 Apr 2025 for the purpose of Medifast Inc First Quarter Earnings Conference Call for 2025 See details

Medifast Inc Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	130.4
PE TTM High in industry Unavailable in chosen country	62.3
PEG TTM Negative PEG TTM Unavailable in chosen country	-0.6
Price to Book Below industry Median Unavailable in chosen country	0.6
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	79.6
Revenue Growth Qtr YoY % Negative Revenue Growth Qtr YoY % Unavailable in chosen country	-37.7
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-43.8
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-86.7
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-97.9
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	0.6
Operating Profit Margin TTM % Low in industry Unavailable in chosen country	0.5
Piotroski Score Below industry Median Unavailable in chosen country	5
Rel Perf vs Sector quarter% Unavailable in chosen country	-15.3
ROE Annual % Below industry Median Unavailable in chosen country	1
RoA Annual % Below industry Median Unavailable in chosen country	0.7

All financials are in USD Million and price data in USD

Medium Financial Strength

38.9 / 100

Affordable Valuation

51.5 / 100

Technically Bearish

27.1 / 100

Falling Comet These stocks are with medium quality with average financials but with good valuation score. However, their weak technical aspects reduces the investor interest. View Similar Embed DVM

1Yr Price target upside is 26%

1 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Sell Zone

98.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Medifast Inc Stock Price Analysis

Day Price Range -1.9% 1 Day return Unavailable in chosen country	11.9 (LTP) 11.912.4 LowHigh
Week Price Range -6.2% 1 Week return Unavailable in chosen country	11.9 (LTP) 11.913.1 LowHigh
Month Price Range -15.7% 1 Month return Unavailable in chosen country	11.9 (LTP) 11.914.6 LowHigh
52 Week Price Range -63.3% 1 Year return Unavailable in chosen country	11.9 (LTP) 11.936.3 LowHigh

View full Share Price History

Medifast Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Medifast Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

0.2

Avg. Estimate

-1

Low Estimate

-1

High Estimate

-1

Current EPS

Avg. Estimate

Miss

EPS is expected to reduce by 652.6% in FY25

Consensus Recommendation

1 ANALYST Recommendations

HOLD

The consensus recommendation from 1 analyst for Medifast Inc is HOLD

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Medifast Inc Stock Analysis

Medifast Inc stock analysis with key metrics, changes, and trends.

Medifast Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$602.46 M	43.8%	negative	Annual Revenue fell 43.8%, in the last year to $602.46 M. Its sector's average revenue growth for the last fiscal year was 8.12%.
Annual Net Profit	$2.09 M	97.9%	negative	Annual Net Profit fell 97.9% in the last year to $2.09 M. Its sector's average net profit growth for the last fiscal year was 3.53%.
Price to Earning Ratio	62.32	-	negative	Price to Earning Ratio is 62.32, higher than its sector PE ratio of 22.77.
Stock Price	$11.92	-63.26%	negative	Stock Price fell 63.26% and underperformed its sector by 67.44% in the past year.
Quarterly Revenue	$119 M	37.7%	negative	Quarterly Revenue fell 37.7% YoY to $119 M. Its sector's average revenue growth YoY for the quarter was 9.6%.
Quarterly Net profit	$0.8 M	86.73%	negative	Quarterly Net profit fell 86.73% YoY to $0.8 M. Its sector's average net profit growth YoY for the quarter was 36.99%.
Debt to Equity Ratio	0.08	-	positive	Debt to Equity Ratio of 0.08 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	1.02 %	1.02%	negative	Return on Equity(ROE) for the last financial year was 1.02%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	43.51 %	-1.1%	negative	Mutual Fund Holding decreased by 1.1% in the last quarter to 43.51.
Promoter Share Holding	3.63 %	1.25%	positive	Promoter Share Holding increased by 1.25% in the most recent quarter to 3.63%.
Institutional Holding	79.64 %	0.03%	positive	Institutional Holding increased by 0.03% in the last quarter to 79.64.

VIEW LESS

Loading data..

Medifast Inc - Company Profile

What does Medifast Inc do?

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Gross Remuneration

2024

Gross Remuneration

Year

Medifast Inc Live Share Price Today, Share Analysis and Chart

New 52W Low in past week

Medifast Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Medifast Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Medifast Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Medifast Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to reduce by 652.6% in FY25

Consensus Recommendation

The consensus recommendation from 1 analyst for Medifast Inc is HOLD

Medifast Inc Stock Analysis

Medifast Inc stock analysis with key metrics, changes, and trends.

Annual Revenue fell 43.8%, in the last year to $602.46 M. Its sector's average revenue growth for the last fiscal year was 8.12%.

Annual Net Profit fell 97.9% in the last year to $2.09 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio is 62.32, higher than its sector PE ratio of 22.77.

Stock Price fell 63.26% and underperformed its sector by 67.44% in the past year.

Quarterly Revenue fell 37.7% YoY to $119 M. Its sector's average revenue growth YoY for the quarter was 9.6%.

Quarterly Net profit fell 86.73% YoY to $0.8 M. Its sector's average net profit growth YoY for the quarter was 36.99%.

Debt to Equity Ratio of 0.08 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 1.02%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 1.1% in the last quarter to 43.51.

Promoter Share Holding increased by 1.25% in the most recent quarter to 3.63%.

Institutional Holding increased by 0.03% in the last quarter to 79.64.

Medifast Inc - Company Profile

What does Medifast Inc do?

Medifast Inc Management structure

Mr. Daniel R. Chard

Chief Executive Officer and Chairman of the Board

Mr. James P. Maloney

Chief Financial Officer

Mr. Jonathan Barrett MacKenzie

Vice President, Finance and Chief Accounting Officer

Medifast Inc Board of directors

Mr. Daniel R. Chard

Chief Executive Officer and Chairman of the Board

Mr. Jeffrey J. Brown

Lead Independent Director

Mr. Scott Schlackman

Independent Director

Mr. Michael A. Hoer

Independent Director